The Eric Ries Show cover image

His First Company Went Public For $3.5 Billion, Now He’s Reversing Type 2 Diabetes For 100 Million

The Eric Ries Show

00:00

Rethinking GLP-1 Medications for Long-Term Health

Exploring the potential of GLP-1 drugs in treating diabetes and obesity while emphasizing concerns about their long-term effects. The chapter advocates for a shift towards nutrition and behavioral changes as a primary strategy over lifelong medication dependence.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app